Pelubiprofen

Nonsteroidal anti-inflammatory drug

Pelubiprofen
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Pelubiprofen is a nonsteroidal anti-inflammatory drug (NSAID) used primarily for its analgesic and anti-inflammatory properties. It is commonly prescribed for the treatment of rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders.

Pharmacology

Pelubiprofen works by inhibiting the cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins. Prostaglandins are mediators of inflammation and pain, and by reducing their production, pelubiprofen alleviates symptoms associated with inflammatory conditions.

Mechanism of Action

Pelubiprofen selectively inhibits the COX-2 enzyme, which is primarily responsible for the synthesis of inflammatory prostaglandins. This selectivity helps in reducing inflammation and pain while minimizing gastrointestinal side effects commonly associated with non-selective COX inhibitors.

Clinical Uses

Pelubiprofen is indicated for the management of pain and inflammation in conditions such as:

• Rheumatoid arthritis
• Osteoarthritis
• Ankylosing spondylitis
• Acute musculoskeletal pain

Side Effects

Common side effects of pelubiprofen include:

• Gastrointestinal discomfort
• Nausea
• Dizziness
• Headache

Serious side effects, although rare, may include:

• Gastrointestinal bleeding
• Renal impairment
• Hepatotoxicity

Synthesis

Synthesis of Pelubiprofen

The synthesis of pelubiprofen involves the condensation of 4-bromobenzoyl chloride with 2-methylpropionic acid, followed by a series of reactions to form the final product. The process is designed to optimize yield and purity, ensuring the production of a pharmacologically active compound.

Related pages

• Nonsteroidal anti-inflammatory drug
• Cyclooxygenase
• Prostaglandin